Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stryckmans

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Bioconjugate Chemistry|November 1, 1990
Hinge-thiol coupling of monoclonal antibody to silanized iron oxide particles and evaluation of magnetic cell depletionP Hermentin, R Doenges, U Franssen, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumorsR A Stahel, J P Sculier, L M Jost, et al.
Journal of the National Cancer Institute|April 21, 1993
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupH Döhner, A D Ho, J Thaler, et al.
Cancer Treatment Reviews|September 1, 1990
Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasmsA D Ho, J Thaler, R Willemze, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of CancerA D Ho, S Suciu, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative GroupA D Ho, S Suciu, P Stryckmans, et al.
Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Bioconjugate Chemistry|November 1, 1990
Hinge-thiol coupling of monoclonal antibody to silanized iron oxide particles and evaluation of magnetic cell depletionP Hermentin, R Doenges, U Franssen, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumorsR A Stahel, J P Sculier, L M Jost, et al.
Journal of the National Cancer Institute|April 21, 1993
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupH Döhner, A D Ho, J Thaler, et al.
Cancer Treatment Reviews|September 1, 1990
Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasmsA D Ho, J Thaler, R Willemze, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of CancerA D Ho, S Suciu, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative GroupA D Ho, S Suciu, P Stryckmans, et al.
Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Pageof 14